Cabaletta Bio (CABA) Share-based Compensation Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | -21.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.31% |
| Sep 30, 2025 | 134.38% |
| Jun 30, 2025 | 119.76% |
| Mar 31, 2025 | 36.14% |
| Dec 31, 2024 | 77.35% |
| Sep 30, 2024 | 155,351.13% |
| Jun 30, 2024 | 186,394.25% |
| Mar 31, 2024 | 52.86% |
| Dec 31, 2023 | 93.35% |
| Sep 30, 2023 | -99.91% |
| Jun 30, 2023 | -99.84% |
| Mar 31, 2023 | 36.94% |
| Dec 31, 2022 | -1.44% |
| Sep 30, 2022 | 153.44% |
| Jun 30, 2022 | 25.29% |
| Mar 31, 2022 | 38.24% |
| Dec 31, 2021 | 21.20% |
| Sep 30, 2021 | 16.16% |
| Jun 30, 2021 | 39.31% |
| Mar 31, 2021 | 50.06% |
| Dec 31, 2020 | 61.29% |
| Sep 30, 2020 | 1,236.36% |
| Jun 30, 2020 | 1,015.91% |
| Mar 31, 2020 | 76.01% |
| Dec 31, 2019 | 192.50% |
| Sep 30, 2019 | -77.44% |